Experts
At Argent BioPharma, our mission is to revolutionize healthcare through pioneering innovation.
We go beyond traditional disease management by exploring the intricacies of the immune system and harnessing cutting-edge technologies in our research and development endeavors.
Through our commitment to advancing medical science, we aim to reshape the landscape of global healthcare by addressing unmet needs and offering hope to underserved populations worldwide.
Our vision encompasses becoming a leading biopharmaceutical company renowned for groundbreaking medical treatments. By embracing NanoPolyPharmacology, we strive to introduce impactful solutions that elevate standards within the life sciences industry. Our dedication extends to ensuring accessibility to innovative therapies for communities overlooked by conventional medical approaches, thereby bridging healthcare disparities on a global scale.
As we progress on this ambitious path, we invite you to follow our journey and be a part of a transformative shift in healthcare. At Argent BioPharma, we’re not just changing treatments; we’re changing lives.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
MGC starts European grand tour in Ireland
Health & Biotech
MGC hits a landmark deal with key strategic partnership to launch into Latin America
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
MGC Pharma reaches four-figure prescription milestone ahead of schedule
Health & Biotech
MGC Pharma steps on the gas as prescription momentum continues to build
Health & Biotech
600 prescriptions have now been written for MGC Pharma medicinal cannabis products
Health & Biotech
MGC Pharma growth accelerates as prescription sales double in two weeks
Health & Biotech
Weed Week: There’s a wave of THC-related vaping illnesses sweeping the US
Health & Biotech
MGC Pharma hits key milestone as prescription growth accelerates for its medicinal cannabis drugs
Health & Biotech
Ethics body approves another clinical trial using MGC Pharma’s epilepsy drug
Health & Biotech
Weed Week: G-men getting on the hype train
Health & Biotech
Health: Cann flags upgrade at Mildura production facility, shares bounce off recent lows
Health & Biotech
Driver, surprise me: MGC Pharma to test epilepsy drug on driving performance
Health & Biotech
MGC Pharma raises $4.8m ahead of UK listing
Health & Biotech
Aussie momentum building for MGC Pharma amid milestones
Health & Biotech
Lock it in: MGC Pharma will be researching and producing cannabis in Europe for decades
News